This is Ruby Gadelrab's Typepad Profile.
Join Typepad and start following Ruby Gadelrab's activity
Join Now!
Already a member? Sign In
Ruby Gadelrab
Silicon Valley, California
Biotechnology marketing professional, specialising in genomics, cancer research and personalized medicine
Interests: Biotechnology, genomics, cancer research, direct to consumer genetics, pharmacogenomics, molecular diagnostics. Apart from my exciting career, I am also a foodie, a fashionista, a news and book junkie and a lover of social media and shoes.
Recent Activity
this is a very interesting test and great example of molecular genomic tools being used in a clinical setting with a real clinical utility thats also recieved FDA clearance. Pathwork Dx did a great job on identifying the signatures developing the assay and the algorithim and the arrays are made for them by Affymetrix. I really look forward to seeing them do well in the Cancer diagnostics space. (commentary purely my own opinion and not representative of my employer)
1 reply
mine is great J, helps that she is my friend too, in fact you have communicated with her - Gladys - remember I put you in contact with her? you guys should reconnnect - i think you would both benefit!
Ruby Gadelrab is now following justinokelly
Jan 10, 2010
Ten years ago this June, Bill Clinton and Tony Blair announced that the first draft of the human genome had been completed by scientists. The politicians were a tad premature -- the draft was not published until 2001, the "finished" genome sequence took several more years, and a few small segments are still unread. But the achievement remains a huge landmark in self-knowledge for our species, and an anniversary that deserves the great attention it is certain to get. via Continue reading
Posted Jan 4, 2010 at Ruby Gadelrab's blog
Looking back, most of us will remember 2009 for the incredible swing in fortune it offered to the biotech industry, from widespread survival concerns in the first quarter to some record-making deals in the fourth. But some of last year's developments point to how the industry may evolve in the coming decade. Here, in no particular order, are some of 2009's trends and stories that are shaping our future: via Continue reading
Posted Jan 4, 2010 at Ruby Gadelrab's blog Continue reading
Posted Jan 4, 2010 at Ruby Gadelrab's blog
During the summer of 2009, I came across a fascinating Genetic Study that I decided to participate in Part 1 of this blog will describe the study and some of its features I particularly liked. In Part 2, I will share some of my personal experiences in participating in the study. The Coriell Personalized Medicine Collaborative (CPMC) is a research study with a goal of understanding if personalized genetic information can be used to improve health outcomes. Participants are asked to contribute a Saliva Sample (by spitting a lot in a plastic tube) which is then screened for genetic variants, which can be attributable to common diseases and predict responses to certain medications. The participants are also asked to complete an online profile of themselves in which they are asked a series of questions on their lifestyle, family history, current health and medications used. This information in combination with the test is used to generate a personalized genetic report which is viewable by the participant online, once the results are available. That’s it – it’s free and it’s really simple. I wanted to highlight a few of the features of the study that I particularly liked The complex diseases/that are... Continue reading
Posted Jan 1, 2010 at Ruby Gadelrab's blog
This 3-day conference brought together scholars involved in the ethical, legal and social controversies around the rapidly developing field of personalized genomics. More than 100 leading international experts in law, ethics, communications studies, genomic medicine and research came together for in-depth discussion on key issues, such as research ethics and governance challenges, the integration of personalized genomics into healthcare, media and popular representation of personal genomics, commercialization of personalized genomics and the regulation of direct-to-consumer (DTC) genetic testing. Here, I focus on a few topics that were discussed during the conference and that will continue to raise debate in the field of personalized genomics. via Great Quick summary of the 5th International DNA Sampling Conference. Continue reading
Posted Jan 1, 2010 at Ruby Gadelrab's blog
The Texans completely don't understand me - I'm of Egyptian origin but that doesn't occur to them, they think I'm Mexican and when I start speaking with and English accent they are completely confused! The Lebanese was @Marroush - I'm sure you have tried it being a Londoner - I cant find good Lebanese in SF!
great list of things to hope for in 2010 - lets hope we see them soon! (@divabiotech)
Toggle Commented Dec 31, 2009 on A Happy New Year to y'all... at Onco Chat
1 reply
China is way more advanced and much more developed than I thought it was. The whole world is hungry for knowledge on genomics information and how it will change medicine and impact them. I have feasted around the world and yet still crave home cooking Singapore is the most civilized country with the best and fastest airports I have ever been to. France has the best deserts and pastries in the world. Singapore has the best pepper and chilli crab I’ve ever tasted. Hong Kong has the best dumplings and street food. London has the best Lebanese food that I crave. The Peking duck in Beijing doesn’t taste like the Peking duck in the US or UK – its much much better! People of Jewish decent are not allowed to enter Saudi Arabia and women must be accompanied by a male at all times! (Shocking!) The great wall of China is the most overwhelming, picturesque place I have visited especially when covered in an inch of snow People in Texas think I’m a weird Hispanic looking girl who talks in a very strange accent. Social media is addictive but the addiction can be turned into a very functional tool for... Continue reading
Posted Dec 31, 2009 at Ruby Gadelrab's blog
It was the decade that launched a new age of science, and it came as no surprise. Researchers had foreseen the rise of biology in the 1990s and expected nothing less than a transformation of modern medicine and giant leaps in our knowledge of life on Earth. via Continue reading
Posted Dec 31, 2009 at Ruby Gadelrab's blog The link for the download
The PWC report on personalized medicine is available for download,the link to the download is The topics include The heart of the matter 2 Personalized medicine is presenting new challenges and opportunities for players within and beyond the health industry. Collaboration will be a key to success. An in-depth discussion 6 Personalized medicine is redefining the health industry and disrupting existing business models. Personalized medicine: the new science 7 Reinventing the Traditional “Big Pharma” Model 14 Molecular diagnostics: an early winner 17 Technology-based opportunities 22 Healthcare providers in flux 24 Payers’ actions will drive the business models of other participants 26 Government must be an enabler, not an obstacle 28 Much progress has been made but many challenges remain 33 What this means for your business 34 Sustainability will require a long-term strategy, cross-industry collaboration, and technical expertise. Organizations will profit together, not alone 35 Successful organizations will keep their eyes on the prize: consumers 40 Expertise matters 42 Personalized medicine is a marathon, not a sprint 43 Conclusion 45 Continue reading
Posted Dec 30, 2009 at Ruby Gadelrab's blog
NHS Starts Pilot Program to Increase Doctors' Genetics Knowledge July 30, 2009 By a GenomeWeb staff reporter NEW YORK (GenomeWeb News) – The UK's National Health Service wants to prepare its physicians for the changes that personalized and genomic medicine will bring to the healthcare field and has invested £4.5 million ($7.4 million) in a new pilot program to begin that process. The goal of the new program is to provide enhanced training in genetic technologies and clinical applications for healthcare scientists working in laboratory genetics. Funded by the Department of Health under the UK Modernizing Scientific Careers programme, the pilot will begin to "address the training needs of the healthcare science workforce in genetics," the Department of Health said today. Set to begin in October, the program will fund 24 pilot training posts for 12 trainee Healthcare Science Practitioners and 12 Healthcare Scientists in Genetics. These trainees will be based in a number of NHS genetics departments throughout England, and they will meet for national training events. The pilot will have four components and goals including establishing a national School of Genetics in the West Midlands; modernizing the genetics curricula to respond to breakthrough scientific advances and their applications... Continue reading
Posted Dec 27, 2009 at Ruby Gadelrab's blog
The discovery could lead to new treatments for the conditions which affects one million children in Britain. Scientists in America found the gene called DEBNND1B sets off a chain reaction that causes the immune system to overreact to irritants, triggering symptoms such as difficulty breathing and wheezing. The findings are published online by the New England Journal of Medicine. Only on other gene has been found that increases the chances of developing asthma. Lead author Dr Hakon Hakonarson, director of the Center for Applied Genomics at The Children's Hospital of Philadelphia, compared the genes of 793 children with persistent asthma to those to 1,988 children without to discover those with the disease had a variation in their genetic code. Dr Hakonarson said: "We now know that the DENND1B gene and its protein are involved in the release of cytokines, which are signalling molecules that in this case tell the body how it should respond to foreign particles. "Many of these particles are well-known triggers of asthma. In asthma, patients have an inappropriate immune response in which they develop airway inflammation and overreaction of the airway muscle cells, referred to as airway hyperresponsiveness. "The gene mutations in DENND1B appear to lead... Continue reading
Posted Dec 27, 2009 at Ruby Gadelrab's blog
This article has been updated to include statistics from Genomic Health characterizing Oncotype DX's reimbursement in the node-positive and node-negative population. The article has been changed to include the company's estimate on the patient population receiving an "intermediate" recurrence score from Oncotype DX. via this would make great strides in breast cancer therapy selection as well as the future of more molecular based diagnostics. Continue reading
Posted Dec 26, 2009 at Ruby Gadelrab's blog
Ruby Gadelrab is now following daisy barringer
Dec 26, 2009
Ruby Gadelrab is now following Pim
Dec 26, 2009
Ruby Gadelrab is now following Seth Godin
Dec 26, 2009
Ruby Gadelrab is now following malcolmgladwell
Dec 26, 2009
Ruby Gadelrab is now following The Typepad Team
Dec 26, 2009